Clinical Trial Update: FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC) [Phase 2]

View source ↗

Summary

Phase 2 trial in advanced gastric cancer comparing two sequencing strategies of FOLFOX and FOLFIRI; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Dong-A University Hospital | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED